Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Adam Nelson

Dr Adam Nelson

Why is LDL Control Important?

Dr Andrew Leech

Dr Andrew Leech

Managing Paediatric Anxiety in General Practice

Dr Terri Foran

Dr Terri Foran

Non-Hormonal & Hormonal Options for Hot Flushes

Dr Anita Munoz

Dr Anita Munoz

Muscle Health in Chronic Disease: A Practical Guide for GPs

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024